ArticleHuman molecular genetics2018

AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease.

Michael P Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.